Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Physical Review. E|May 20, 2022
Critical pressure in liquids due to dynamic chokingJiří Vacula, Pavel NovotnýViruses|October 26, 2021
Precursors of Viral Proteases as Distinct Drug TargetsTaťána Majerová, Pavel NovotnýBiochimie|May 12, 2019
Exploiting the unique features of Zika and Dengue proteases for inhibitor designTaťána Majerová, Pavel Novotný, Eliška Krýsová, et al.International Orthopaedics|February 26, 2013
Bilateral scapular fractures in adultsMichal Tuček, Jan Bartoníček, Pavel Novotný, et al.Cancers|September 13, 2025
Modern Approaches to Rectal Cancer: Integrating Endoscopic, Surgical, and Oncological CareJiří Kotek, Jiří Cyrany, Miroslav Sirový, et al.International Journal of Biological Macromolecules|February 13, 2026
Trapping SARS-CoV-2 main protease into transient artificial zymogens for high-yield expression and simplified purificationPavel Novotný, Adéla Moravcová, Veronika Nováková, et al.The Journal of Biological Chemistry|December 15, 2024
The zymogenic form of SARS-CoV-2 main protease: A discrete target for drug discoveryPavel Novotný, Jana Humpolíčková, Veronika Nováková, et al.Nature Communications|August 12, 2025
Irreversible furin cleavage site exposure renders immature tick-borne flaviviruses fully infectiousJiří Holoubek, Jiří Salát, Milos Matkovic, et al.Trials|March 2, 2021
Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trialJan Maláska, Jan Stašek, František Duška, et al.Trials|January 16, 2022
Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)-study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trialJan Maláska, Jan Stašek, František Duška, et al.Pageof 2